Company identity
Browse spinoutsCompany number 04599525
Company profile
UK company 04599525, incorporated on 25 November 2002.
Nanosight Limited is a UK company with status active founded in 2002 based in West Midlands.
Company number 04599525
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Company registered at Companies House
The NanoSight Pro, developed by Malvern Panalytical, is a nanoparticle analyzer which uses laser modules and fluorescence signals to provide high-resolution size and concentration data for nano- and biomaterials. The NS Xplorer software enables intelligent and automated measurements, eliminating human error and improving efficiency.
Malvern Panalytical develops and manufactures analytical instruments for characterizing and measuring materials.
NanoSight visualizes, measures and characterizes virtually all nanoparticles. Particle size, concentration, zeta potential and aggregation can all be analyzed while a fluorescence mode provides speciation of labeled particles. NanoSight provides real time monitoring of the subtle changes in the characteristics of particle populations with all of these analyses uniquely confirmed by visual validation. http://www.nanosight.com/
In 2011 NanoSight won Technology World's 2011 Business Innovation Award and was recognised by Deloitte as the UK's Fastest Growing Biotech Company . In 2012 NanoSight wins Queen's Award for Enterprise for International Trade, having achieved their 450th instrument sale with more than 400 third party papers citing NanoSight technology. Much of this success has come directly from our collaboration with them in which we use their technology to measure microvesicles and exosomes in biological fluids. 2011 NanoSight wins Technology World's 2011 Business Innovation Award NanoSight Recognised by Deloitte as the UK's Fastest Growing Biotech Company in their 2011 Technology Fast 50 Rankings 2013 On the basis of the above success, Nanosight Ltd was sold to Malvern Instruments for £15 million.
1 Apr 2005 to 31 Mar 2008
Awaiting Public Summary